177 related articles for article (PubMed ID: 16358486)
1. [Evaluation of disk diffusion test for carbapenem sensitivity in Acinetobacter baumannii and Pseudomonas aeruginosa strains].
Akan OA; Uysal S
Mikrobiyol Bul; 2005 Jul; 39(3):273-9. PubMed ID: 16358486
[TBL] [Abstract][Full Text] [Related]
2. [Shall we report the carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii strains detected by BD Phoenix system?].
Oğünç D; Ongüt G; Ozen NS; Baysan BO; Günseren F; Dağlar D; Demirbakan H; Gültekin M
Mikrobiyol Bul; 2010 Apr; 44(2):197-202. PubMed ID: 20549953
[TBL] [Abstract][Full Text] [Related]
3. Differences between meropenem and imipenem disk to detect carbapenemase in gram-negative bacilli using simplified carbapenem inactivation method.
Wan D; Jing X; Zhou H; Min X; Zhang X; Wu T; Liu R; Zeng J
J Infect Chemother; 2020 Jun; 26(6):636-639. PubMed ID: 32173284
[TBL] [Abstract][Full Text] [Related]
4. Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii.
Dahdouh E; Shoucair SH; Salem SE; Daoud Z
ScientificWorldJournal; 2014; 2014():979648. PubMed ID: 25610915
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients.
Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
Adv Exp Med Biol; 2013; 788():109-16. PubMed ID: 23835967
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
Douraghi M; Ghalavand Z; Nateghi Rostami M; Zeraati H; Aliramezani A; Rahbar M; Mohammadzadeh M; Ghourchian S; Boroumand MA; Abdollahi A
J Appl Microbiol; 2016 Aug; 121(2):401-7. PubMed ID: 27171885
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa.
Kuti JL; Florea NR; Nightingale CH; Nicolau DP
Pharmacotherapy; 2004 Jan; 24(1):8-15. PubMed ID: 14740783
[TBL] [Abstract][Full Text] [Related]
9. Carbapenem resistance in Acinetobacter baumannii: where is it heading?
Deveci Ö; Dal T; Tekin R; Bozkurt F; Tekin A; Dayan S
Infez Med; 2013 Sep; 21(3):211-5. PubMed ID: 24008854
[TBL] [Abstract][Full Text] [Related]
10. Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
Tamma PD; Wang R; Lewis S; Opene BNA; Simner PJ
Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1378-1379. PubMed ID: 28965496
[No Abstract] [Full Text] [Related]
11. Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii in high complexity hospital.
Baumgart AM; Molinari MA; Silveira AC
Braz J Infect Dis; 2010; 14(5):433-6. PubMed ID: 21221469
[TBL] [Abstract][Full Text] [Related]
12. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
Goyal K; Gautam V; Ray P
Indian J Med Microbiol; 2012; 30(3):350-1. PubMed ID: 22885206
[TBL] [Abstract][Full Text] [Related]
13. The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre.
van der Bij AK; Mol M; van Westreenen M; Goessens WH; Pitout JD
Scand J Infect Dis; 2011 Aug; 43(8):596-602. PubMed ID: 21506891
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro activity of doripenem, imipenem and meropenem against clinical isolates of Enterobacteriaceae, Pseudomonas and Acinetobacter in Southern Poland.
Drzewiecki A; Bulanda M; Talaga K; Sodo A; Adamski P
Pol Przegl Chir; 2012 Sep; 84(9):449-53. PubMed ID: 23241660
[TBL] [Abstract][Full Text] [Related]
15. Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Valenza G; Seifert H; Decker-Burgard S; Laeuffer J; Morrissey I; Mutters R;
Int J Antimicrob Agents; 2012 Mar; 39(3):255-8. PubMed ID: 22230334
[TBL] [Abstract][Full Text] [Related]
16. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
17. Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.
Esterly JS; Qi C; Malczynski M; Scheetz MH
Pharmacotherapy; 2010 Apr; 30(4):354-60. PubMed ID: 20334455
[TBL] [Abstract][Full Text] [Related]
18. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
[TBL] [Abstract][Full Text] [Related]
19. [Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp].
Sacha P; Wieczorek P; Jakoniuk P; Zórawski M
Wiad Lek; 2008; 61(1-3):30-6. PubMed ID: 18717040
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
